Shares of Novavax Inc. NVAX, +0.32% were up 2.4% in trading on Monday after the company said its COVID-19 booster has been authorized in Europe for adults. Novavax’s stock has declined 77.3% so far this year, while the S&P 500 SPX, +0.78% is down 14.6%.